Join Professor Iain McInnes and Professors Hideto Kameda and Rieke Alten for the latest episode on The Immune-Mediated Inflammatory Disease Forum, where they discuss the latest information and data in RA.
In this episode, they discuss two papers which investigate the long-term efficacy and safety of upadacitinib in the SELECT trials.
